206 related articles for article (PubMed ID: 24746091)
21. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S
PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340
[TBL] [Abstract][Full Text] [Related]
23. Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection.
Qiao Y; Chen J; Li X; Wei H; Xiao F; Chang L; Zhang R; Hao X; Wei H
Clin Biochem; 2014 Nov; 47(16-17):216-22. PubMed ID: 25168922
[TBL] [Abstract][Full Text] [Related]
24. [Survey of the serum hepatocellular carcinoma marker Golgi glycoprotein (GP73) among Qidong residents and correlation analysis to outcome at two-year follow-up].
Chen JG; Zhu YR; Lu WZ; Zhang YH; Lu JH
Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):780-4. PubMed ID: 23207341
[TBL] [Abstract][Full Text] [Related]
25. [Significance of serum golgi protein 73 (GP73), alpha-fetoprotein (AFP) and lectin-reactive alpha-fetoprotein (AFP-L3) expresssion in primary hepatic carcinoma].
Xu WF; Fei YM; Zhou JK; Shen HJ; Chen XF; Lv QQ; Ding YY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):286-8. PubMed ID: 22097609
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a magnetic particles-based chemiluminescence enzyme immunoassay for Golgi protein 73 in human serum.
Liu X; Wan X; Lu S; Zhang L; Yu S; Lu X
Clin Chim Acta; 2015 May; 445():54-9. PubMed ID: 25801213
[TBL] [Abstract][Full Text] [Related]
27. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
28. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
29. Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma.
Jiang J; Wu C; Shen Y; Xu B; Zheng X; Li X; Xu N
Anticancer Res; 2011 Feb; 31(2):687-91. PubMed ID: 21378357
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
[TBL] [Abstract][Full Text] [Related]
31. Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases.
Tian L; Wang Y; Xu D; Gui J; Jia X; Tong H; Wen X; Dong Z; Tian Y
Int J Cancer; 2011 Oct; 129(8):1923-31. PubMed ID: 21140449
[TBL] [Abstract][Full Text] [Related]
32. The Value of GPC3 and GP73 in Clinical Diagnosis of Hepatocellular Carcinoma.
Jing JS; Ye W; Jiang YK; Ma J; Zhu MQ; Ma JM; Zhou H; Yu LQ; Yang YF; Wang SC
Clin Lab; 2017 Nov; 63(11):1903-1909. PubMed ID: 29226636
[TBL] [Abstract][Full Text] [Related]
33. Combined detection of AFP-L3, GP73 and TIP30 enhances diagnostic accuracy for HBV-related cirrhosis and hepatocellular carcinoma.
Yanming L; Yue C; Wencan C; Liangyin WU; Xijun L; Jiafeng Z; Fengping HE
J Pak Med Assoc; 2019 Sep; 69(9):1279-1286. PubMed ID: 31511712
[TBL] [Abstract][Full Text] [Related]
34. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
36. The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors.
Bröker ME; Ijzermans JN; Witjes CD; van Vuuren HJ; de Man RA
PLoS One; 2014; 9(7):e100187. PubMed ID: 25033446
[TBL] [Abstract][Full Text] [Related]
37. [Expression of miR-212 and miR-132 in serum of patients with primary liver cancer and their targeted regulation of GP73].
Sha M; Wang B; Xiao L; Ye J; Wang J; Luan ZY
Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):920-926. PubMed ID: 29325293
[No Abstract] [Full Text] [Related]
38. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
[TBL] [Abstract][Full Text] [Related]
39. Golgi protein 73(GP73), a useful serum marker in liver diseases.
Liu X; Wan X; Li Z; Lin C; Zhan Y; Lu X
Clin Chem Lab Med; 2011 Aug; 49(8):1311-1316. PubMed ID: 21663469
[TBL] [Abstract][Full Text] [Related]
40. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
